Publication | Closed Access

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells

Hematological MalignancyOncologyHealth SciencesActivated NkMedicineImmunologyHematologyAutoimmunityMultiple MyelomaAdult T-cell Leukemia-lymphomaRadiation OncologyImmunotherapyCell TransplantationSalvage Therapy